Carbidopa/Levodopa: Side effects, Formulations and Dosages For Treating Parkinson’s Disease Skip to a section below: General questions Formulations Side...see more effects Dosages Understand the basics of Carbidopa/Levodopa and how it affects the brain Loss of neurons in the brain that use dopamine to communicate is one of the hallmark features of Parkinson’s disease (PD), causing slowness, […]
The American Parkinson Disease Association (APDA) launches today a new and improved APDA Symptom Tracker App 2.0 – a...see more highly-specialized mobile application for people living with Parkinson’s disease (PD). The updated version remains free of charge and features enhanced functionality which will significantly improve the ability of a person with Parkinson’s disease (PD) to easily and accurately track their PD symptoms and medications, and relay that important information to members of their medical team; with the ultimate goal of receiving better, more personalized care.
The American Parkinson Disease Association (la Asociación Americana de Enfermedad de Parkinson o APDA ) lanza una aplicación nueva...see more y aumentada, la App El Diario de síntomas de la APDA 2.0-una aplicación móvil especializada para personas viviendo con la enfermedad de Parkinson (EP). Esta versión actualizada es gratis y contiene funciones amplificadas para facilitar el seguimiento de los síntomas y medicamentos para las personas con EP, y poder relatar esa información a los miembros de su equipo de atención médica; con la meta de recibir cuidado de salud que es personalizado para cada persona.
ARCHIVED: Free Webinar Hosted by University at Albany Aired on: Thursday, July 20, 2017 Watch Here University at Albany...see more hosted a free live webcast for medical and public health professionals, featuring guest speaker Guy J. Schwartz, MD, the Assistant Clinical Professor of Neurology at Stony Brook University Medical Center. In depth, Guy discussed the psychiatric symptoms […]
2016 World Parkinson Congress Leadership Forum Before the 4th World Parkinson Congress officially kicked-off in Portland, Oregon nearly 200...see more Parkinson’s Organizational Partners gathered to network and learn from each other at the first ever WPC Leadership Forum. The Forum allowed PD Advocacy Leaders to talk about their outreach, fundraising, and educational efforts and to strategize […]
APDA funded researcher published in Journal of Neuroscience – July 2016 APDA funded research demonstrates that alpha-synuclein inclusion formation...see more in neurons can be blocked and that novel therapeutic compounds targeting this process by inhibiting LRRK2 kinase activity may slow progression of PD-associated pathology. In 2013 and 2014, APDA awarded research grants to Laura Vopicelli-Daley, PhD, […]
The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis is now available...see more through NUPLAZIDconnect™ Patient Access and Support Services The American Parkinson Disease Association is pleased to share the news that ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address […]
The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with...see more Parkinson’s Disease Psychosis U.S. Commercial Launch Planned for June 2016 The American Parkinson Disease Association is pleased to share the news that ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative […]
PITTSBURGH, June 15, 2015 – Gene therapy to...see more reduce production of a brain protein successfully prevented development of Parkinson’s disease in an animal study, according to researchers at the University of Pittsburgh School of Medicine. The findings, published online today in the Journal of […]
Unique symptoms of Parkinson’s can be mishandled and misunderstood in emergency situations. This new web-based program will educate police,...see more fire fighters and emergency service providers and help save lives. NEW YORK, NY, January 10, 2017 — The American Parkinson Disease Association (APDA) has partnered with the Office of Continuing Professional Education (OCPE) at Rutgers, The […]